Medable Launches Agent Studio

Medable, a technology provider for clinical development, has launched Agent Studio: an agentic AI platform purpose-built for life sciences.

Agent Studio is a no-code agent-builder that enables clinical teams to quickly custom-configure AI agents. Medable also introduced CRA Agent, an out-of-the-box agent running on Agent Studio that is specifically designed for clinical trial monitoring. Both Agent Studio and CRA Agent will drive efficiencies across the clinical development life cycle and remove bottlenecks hindering scientific advancement.

Medable’s new Agent Studio empowers teams to create purpose-fit agents that solve key clinical development bottlenecks to eliminate white space across complex trial workflows such as protocol development and trial planning and optimization.

“Agent Studio is more than just technology – it’s a catalyst to unleash greater human potential in life sciences,” said Dr. Michelle Longmire, CEO and co-founder of Medable. “It frees teams from the bottlenecks of legacy systems, accelerates trials, reduces costs, and ultimately helps bring medicines to patients faster. We believe this is a once-in-a-generation leap forward in how clinical research gets done.”

Agent Studio is informed by Medable’s deep expertise in clinical research and shaped by insights from researchers, clinical trial operators, and regulators on the front lines of clinical development. It brings the industry closer to Medable’s “1:1:1” vision – one-day study start, one-day patient recruitment, and one-year study conduct – with the goal to get effective therapies to people faster.

CRA Agent, the first of Medable’s pre-built agents, aggregates and summarizes data across systems, supports human-in-the-loop oversight for critical areas, and automates routine monitoring and communication. With CRA Agent, clinical research associates are free to focus on what matters most.